Camblong Jurgi 4

What Happened
Jurgi Camblong, Executive Chairman and director of SOPHiA GENETICS SA (SOPH), sold 8,500 shares on July 10, 2026 for a total of approximately $47,791. The reported weighted-average price was $5.62 per share; the shares were sold in multiple transactions at prices ranging from $5.53 to $5.77. The sale was made pursuant to a pre-established trading plan under Rule 10b5-1(c).

Key Details

• Transaction date: July 10, 2026. Form 4 filed July 14, 2026 (appears timely; Form 4 is due within two business days).
• Type: Sale (S) — open-market sales in multiple tranches.
• Quantity and value: 8,500 shares sold for a weighted-average price of $5.62, total ≈ $47,791.
• Price range: $5.53 to $5.77 (weighted average reported; the filer can provide a breakdown on request).
• Footnotes: F1 — sale under a duly adopted 10b5-1(c) plan; F2 — weighted-average price with range and availability of per-trade breakdown.
• Shares owned after the transaction: Not specified in the provided filing excerpt.

Context
This was a planned disposition under a 10b5-1 trading plan, which is commonly used by insiders to sell shares on a preset schedule and is generally treated as routine rather than a real-time signal of insider sentiment. Sales reduce insider holdings; purchases are usually considered more informative about an insider’s view of the company.